Peppermint Venture Partners

Peppermint Venture Partners (PVP) is a private Venture Capital firm based in Berlin, Germany, dedicated to investing in the transformation of healthcare. The firm focuses on supporting innovative scientists and entrepreneurs who are developing disruptive and novel solutions within the life science sector. Their investment strategy targets companies that enhance efficiency, improve accessibility, contribute to cost containment, and drive the digitization of the healthcare system and the broader life science industry. PVP primarily invests in early-stage companies across Europe, with a particular emphasis on the German-speaking region, seeking out patent-protected technologies that address unmet medical needs to improve diagnosis and therapy while reducing healthcare costs.

The origins of Peppermint Venture Partners trace back to 2000 with the establishment of the first Peppermint Venture Capital Fund by Ingeborg Neumann, who also founded the mid-sized industrial group Peppermint Holding in 1997. The firm was subsequently relaunched as an independent fund manager in 2010. Ingeborg Neumann, along with Dr. Joachim Rautter and Dr. Klaus Stöckemann, are recognized as co-founders and managing partners of the firm.

Peppermint Venture Partners has built a diverse portfolio of life science companies. Notable past investments and exits include Scienion AG and CellAct Pharma GmbH. Current portfolio companies feature CEVEC Pharmaceuticals GmbH, CryoTherapeutics SA, and Labforward GmbH. The firm's investments span various stages, from Seed to Series B and even later-stage venture rounds, with a focus on areas such as medical devices, digital health, and platform technologies.

The PVP team brings together extensive experience in funding, mentoring, and developing transformative life science companies, combined with operational business expertise. Managing Partners Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann lead the firm, leveraging their deep industry knowledge and comprehensive national and international networks. The team's complementary skills and interdisciplinary technical expertise enable them to provide robust support to their portfolio companies throughout their development.